Skip to Content

54 213 54 213 (Lithium Carbonate 150 mg)

Pill with imprint 54 213 54 213 is White, Capsule-shape and has been identified as Lithium Carbonate 150 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; cyclothymic disorder; schizoaffective disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 213 54 213

Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213

Lithium Carbonate

Imprint:
54 213 54 213
Strength:
150 mg
Color:
White
Size:
4.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roxane Laboratories, Inc.
Inactive Ingredients:
FD&C Red No. 40
gelatin
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferrosoferric oxide
povidone k30
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00054-2526 Roxane Laboratories, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide